Screening for hemochromatosis in routine medical care: An evaluation of mean corpuscular volume and mean corpuscular hemoglobin

Genetic Testing

Volumn 4, Issue 2, 2000, Pages 103-110

  Barton, J C ^a,b   Bertoli, L F ^a,b   Rothenberg, B E ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c Billups Rothenberg Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ERYTHROCYTE; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEDICAL CARE; PREDICTION; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ERYTHROCYTE INDICES; FEMALE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0033865948     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/10906570050114786     Document Type: Article

References (46)

1. Clinical presentation of hemochromatosis: A changing scene
2. The megaloblastic anemia
3. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older
4. Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients
5. Population screening for hemochromatosis: Has the time finally come?
6. Normal transferrin saturation in hemochromatosis
7. Iron overload in African Americans
8. Hemochromatosis: Association of severity of iron overload with genetic markers
9. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
10. Diagnosis of hemochromatosis in a community hospital
11. Peripheral blood erythrocyte parameters in hemochromatosis: Evidence for increased erythrocyte hemoglobin content
12. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases
13. Approach to the patient with anemia
14. Mutation analysis in hereditary hemochromatosis
15. Population screening for hemochromatosis: Expectations based on a study of relatives of symptomatic probands
16. The clinical significance of macrocytosis
17. Hemochromatosis: Gene discovery and its implications for populationbased screening
18. Iron overload, public health, and genetics: Evaluating the evidence for hemochromatosis screening
19. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia
20. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus
21. High mean red cell volume: Its incidence and significance in routine haematology
22. High prevalence of the Cys2822Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa
23. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
24. A novel MHC class-I-like gene is mutated in patients with hereditary hemochromatosis
25. Testing for haemochromatosis in the diabetic clinic
26. Iron overload in Africa. Interaction between a gene and dietary iron content
27. Anemia: A diagnostic strategy
28. Screening for hemochromatosis in primary care settings
29. Identification of hemochromatosis homozygotes among U.S. military veterans attending primary care and subspecialty ambulatory clinics at a VA Medical Center: An interim report
30. Interpretation of electronically determined macrocytosis
31. Idiopathic hemochromatosis, an interim report
32. A new syndrome of liver iron overload with normal transferrin saturation
33. If I had a gene test, what would I have and who would I tell?
34. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany
35. Usefulness of biochemical screening of diabetic patients for hemochromatosis
36. Screening for genetic haemochromatosis in a rheumatology clinic
37. Examination of the blood and bone marrow
38. Prevalence of hereditary hemochromatosis in 16031 primary care patients
39. Prevalence of genetic haemochromatosis among diabetic patients
40. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene
41. Heterogeneity of hemochromatosis in Italy
42. Correlation between genotype and phenotype in hereditary hemochromatosis: Analysis of 61 cases
43. Evaluation of a workplace hemochromatosis screening program
44. Screening tests for hemochromatosis
45. Practice parameter for hereditary hemochromatosis